知镜 Cognispect · 医学文献与研究工作台

Hypoactive APOBEC3A Achieves High-Level Mutagenesis and Drives Squamous Cell Carcinoma.

Xu Z, Flensburg C, O'Reilly LA, Bilardi RA, Whitehead LW, Chen DK, Kueh A, Sutherland KD, Majewski IJ.
Cancer research · 2026-11-16 · PMID 43037278

文献摘要

APOBEC proteins shape the somatic mutation spectrum of many cancers by binding and editing DNA. Modeling APOBEC-induced changes in cancer has been challenging due to the toxicity of these enzymes. Here, we overcame this barrier using a mutant form of APOBEC3A with impaired deaminase activity by changing arginine 128 to alanine (A3AR128A). Overexpressing A3AR128A in murine epithelium induced squamous cell carcinoma (SCC) in the skin, head and neck region, and cervix, mirroring the human disease spectrum. Tumor formation was further accelerated by concomitant Trp53 loss. A3AR128A cancers carried frequent alterations in the NOTCH and RAS-PI3K pathways, and recurrent mutations in genes encoding histone H3 were also observed. Cross-species analysis revealed how APOBEC accessibility influences cancer driver gene selection. A catalogue of 235,790 mutations was used to refine mutational signatures linked to A3A. These results shed light on how DNA damage from A3A contributes to tumorigenesis.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。